Novo Nordisk Semaglutide
-
{
- All
- News
'Novo Nordisk Semaglutide' - 1 News Result(s)
-
Novo Responds To GLP-1 Drug Ozempic Causing Vision Loss Claims: What Semaglutide Data Shows
Novo Nordisk says a large pooled analysis of clinical trials found no increased risk of rare NAION with semaglutide. Here is what the new evidence means for diabetes patients in India amid concerns over sudden vision loss.
'Novo Nordisk Semaglutide' - 1 News Result(s)
-
Novo Responds To GLP-1 Drug Ozempic Causing Vision Loss Claims: What Semaglutide Data Shows
Novo Nordisk says a large pooled analysis of clinical trials found no increased risk of rare NAION with semaglutide. Here is what the new evidence means for diabetes patients in India amid concerns over sudden vision loss.
